Imaoka A - Search Results

1

Determination of single-molecule transport activity of OATP2B1 by measuring the number of transporter molecules using electrophysiological approach.

Yajima K, Akiyoshi T, Sakamoto K, Suzuki Y, Oka T, Imaoka A, Yamamura H, Kurokawa J, Ohtani H. Yajima K, et al. Among authors: imaoka a. J Pharmacol Sci. 2023 Nov;153(3):153-160. doi: 10.1016/j.jphs.2023.08.008. Epub 2023 Sep 1. J Pharmacol Sci. 2023. PMID: 37770156 Free article.

2

Decrease in ciprofloxacin absorption by polyvalent metal cations is not fully attributable to chelation or adsorption.

Imaoka A, Hattori M, Akiyoshi T, Ohtani H. Imaoka A, et al. Drug Metab Pharmacokinet. 2014;29(5):414-8. doi: 10.2133/dmpk.dmpk-14-rg-001. Epub 2014 May 6. Drug Metab Pharmacokinet. 2014. PMID: 24806820 Free article.

3

Prediction of the extent and variation of grapefruit juice-drug interactions from the pharmacokinetic profile in the absence of grapefruit juice.

Kogure N, Akiyoshi T, Imaoka A, Ohtani H. Kogure N, et al. Among authors: imaoka a. Biopharm Drug Dispos. 2014 Oct;35(7):373-81. doi: 10.1002/bdd.1904. Epub 2014 Aug 30. Biopharm Drug Dispos. 2014. PMID: 24898424

4

[Current status of illegal trade in pharmaceutical products on Internet auction sites in Japan and responses of site administrators to such transactions].

Ohtani H, Imaoka A, Akiyoshi T. Ohtani H, et al. Among authors: imaoka a. Yakugaku Zasshi. 2015;135(3):529-34. doi: 10.1248/yakushi.14-00238. Yakugaku Zasshi. 2015. PMID: 25759061 Free article. Japanese.

5

Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6.

Akiyoshi T, Ishiuchi M, Imaoka A, Ohtani H. Akiyoshi T, et al. Among authors: imaoka a. Drug Metab Pharmacokinet. 2015 Aug;30(4):321-4. doi: 10.1016/j.dmpk.2015.04.003. Epub 2015 Apr 25. Drug Metab Pharmacokinet. 2015. PMID: 26195224

6

In silico evaluation of warfarin-bucolome therapy.

Ohtani H, Hakoda R, Imaoka A, Akiyoshi T. Ohtani H, et al. Among authors: imaoka a. Biopharm Drug Dispos. 2016 May;37(4):233-42. doi: 10.1002/bdd.2008. Biopharm Drug Dispos. 2016. PMID: 27214159

7

Inactivation kinetics and residual activity of CYP3A4 after treatment with erythromycin.

Ishikawa Y, Akiyoshi T, Imaoka A, Ohtani H. Ishikawa Y, et al. Among authors: imaoka a. Biopharm Drug Dispos. 2017 Oct;38(7):420-425. doi: 10.1002/bdd.2078. Epub 2017 Jul 13. Biopharm Drug Dispos. 2017. PMID: 28425104

8

5-Fluorouracil treatment alters the expression of intestinal transporters in rats.

Yotsumoto K, Akiyoshi T, Wada N, Imaoka A, Ohtani H. Yotsumoto K, et al. Among authors: imaoka a. Biopharm Drug Dispos. 2017 Dec;38(9):509-516. doi: 10.1002/bdd.2102. Epub 2017 Nov 8. Biopharm Drug Dispos. 2017. PMID: 28849584

9

Development and evaluation of an overseas clinical rotation program for undergraduate pharmacy students in Japan.

Ohtani H, Mitsui R, Akiyoshi T, Imaoka A, Abe Y, Kanke M, Nakamura T, Foster P, Mochizuki M. Ohtani H, et al. Among authors: imaoka a. Curr Pharm Teach Learn. 2017 May;9(3):452-459. doi: 10.1016/j.cptl.2016.12.007. Epub 2017 Mar 23. Curr Pharm Teach Learn. 2017. PMID: 29233284

10

5-Fluororacil-Induced Gastrointestinal Damage Impairs the Absorption and Anticoagulant Effects of Dabigatran Etexilate.

Tsujii K, Hattori T, Imaoka A, Akiyoshi T, Ohtani H. Tsujii K, et al. Among authors: imaoka a. J Pharm Sci. 2018 May;107(5):1430-1433. doi: 10.1016/j.xphs.2017.12.023. Epub 2017 Dec 30. J Pharm Sci. 2018. PMID: 29291414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters